Trial Profile
A Single-Dose, Open-Label, Inpatient/Outpatient, Nonrandomized Study Assessing the Pharmacokinetics of Bazedoxifene in Postmenopausal Women with Hepatic Impairment and Matched Healthy Postmenopausal Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Wyeth
- 27 Feb 2018 New trial record